NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN THE USA, CANADA, AUSTRALIA OR JAPAN. The convocation announcement and the agenda, the accompanying explanatory notes and other information and documentation are available on the corporate website of the Company (http://shop-apotheke-europe.com) under Investor Relations / General Meeting / Annual General Meeting 2020 and via the link: http://shop-apotheke-europe.com/en/investorrelations/hauptversammlung/ SHOP APOTHEKE EUROPE gives top priority to the health of its employees, shareholders and other stakeholders when holding the AGM. Normally, the Company's managing board would of course be pleased that you attend the AGM in person. However, today, the Company urges all its shareholders to carefully consider whether they wish to attend the AGM in person this year in view of possible health risks relating to the Covid-19 outbreak. Shareholders who are entitled to attend the AGM, and who choose to be represented and to cast their votes by proxy, can follow the meeting via webcast on 30 April 2020. In addition, those shareholders can ask questions in advance of the AGM. Please refer to Section 3 (General Information) of the convocation announcement for further details regarding the proxy voting option, how to follow the meeting via the webcast and how to ask questions in advance of the AGM. SHOP APOTHEKE EUROPE strives to take the best measures possible in view of the Covid-19 outbreak, while limiting interruption to its business (including the AGM) as much as possible. The option of proxy voting is a good alternative to attendance in person, and enables all of our shareholders to cast their votes on the AGM voting items. Furthermore, shareholders who wish to participate in the AGM are advised to check the AGM page on the Company's corporate website regularly to stay informed about the latest developments.
|
Sprache: | Deutsch |
Unternehmen: | SHOP APOTHEKE EUROPE N.V. |
Dirk Hartogweg 14 | |
5928 LV Venlo | |
Niederlande | |
Telefon: | 0800 - 200 800 300 |
Fax: | 0800 - 90 70 90 20 |
E-Mail: | carmen.herkenrath@shop-apotheke.com |
Internet: | www.shop-apotheke-europe.com |
ISIN: | NL0012044747, DE000A19Y072 |
WKN: | A2AR94, A19Y07 |
Indizes: | SDAX |
Börsen: | Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin, Düsseldorf, Hamburg, Hannover, München, Stuttgart, Tradegate Exchange |
EQS News ID: | 1001935 |
Ende der Mitteilung | DGAP News-Service |
1001935 19.03.2020